Skip to main content

Population Health

By Jeff Lagasse | 03:20 pm | December 31, 2020
Patients with severe allergies to foods, oral drugs, latex or venom can still safely receive the COVID-19 vaccines.
By Mallory Hackett | 01:45 pm | December 31, 2020
The state's nursing homes have seen more than 10,000 COVID-19 cases and close to 2,000 deaths.
By Jeff Lagasse | 12:33 pm | December 31, 2020
The findings give healthcare workers an insight into how patients may be affected, and could lead to more effective treatments.
By Jeff Lagasse | 11:18 am | December 31, 2020
There were no safety issues found, and the side effects have been mild, although more research is needed on its effect on transmission.
By Kat Jercich | 10:56 am | December 31, 2020
Some of the hurdles around vaccine distribution could be addressed with high-tech solutions, particularly where environmental management is concerned.
By Jeff Lagasse | 11:00 am | December 30, 2020
Inequities were found by race/ethnicity, socioeconomic status, age, and when someone used a language other than English.
By Jeff Lagasse | 03:16 pm | December 29, 2020
Roughly 40% of Medicare beneficiaries plan to get a coronavirus vaccine, the highest percentage among all groups.
By Jeff Lagasse | 01:26 pm | December 29, 2020
The investigational vaccine is made from a stabilized form of the coronavirus spike protein using recombinant protein nanoparticle technology.
By Jeff Lagasse | 11:45 am | December 29, 2020
Access and communication are the main barriers to entry for older Americans seeking to utilize virtual care.
By Mallory Hackett | 03:55 pm | December 28, 2020
An individual diabetes patient can expect to pay about $9,600 each year on diabetes medical costs alone.